Abstract:Alteration of the lung microbiome has been observed in several respiratory tract diseases. However, most previous studies were based on 16S ribosomal RNA and shotgun metagenome sequencing; the viability and functional activity of the microbiome, as well as its interaction with host immune systems, have not been well studied. To characterize the active lung microbiome and its associations with host immune response and clinical features, we applied metatranscriptome sequencing to bronchoalveolar lavage fluid (BALF) samples from 25 patients with chronic obstructive pulmonary disease (COPD) and from nine control cases without known pulmonary disease. Community structure analyses revealed three distinct microbial compositions, which were significantly correlated with bacterial biomass, human Th17 immune response, and COPD exacerbation frequency. Specifically, samples with transcriptionally active Streptococcus, Rothia, or Pseudomonas had bacterial loads 16 times higher than samples enriched for Escherichia and Ralstonia. These high-bacterial-load samples also tended to undergo a stronger Th17 immune response. Furthermore, an increased proportion of lymphocytes was found in samples with active Pseudomonas. In addition, COPD patients with active Streptococcus or Rothia infections tended to have lower rates of exacerbations than patients with active Pseudomonas and patients with lower bacterial biomass. Our results support the idea of a stratified structure of the active lung microbiome and a significant host-microbe interaction. We speculate that diverse lung microbiomes exist in the population and that their presence and activities could either influence or reflect different aspects of lung health.IMPORTANCE Recent studies of the microbiome proposed that resident microbes play a beneficial role in maintaining human health. Although lower respiratory tract disease is a leading cause of sickness and mortality, how the lung microbiome interacts with human health remains largely unknown. Here we assessed the association between the lung microbiome and host gene expression, cytokine concentration, and over 20 clinical features. Intriguingly, we found a stratified structure of the active lung microbiome which was significantly associated with bacterial biomass, lymphocyte proportion, human Th17 immune response, and COPD exacerbation frequency. These observations suggest that the microbiome plays a significant role in lung homeostasis. Not only microbial composition but also active functional elements and host immunity characteristics differed among different individuals. Such diversity may partially account for the variation in susceptibility to particular diseases.

Comparative analysis of the lung microbiota in patients with respiratory infections, tuberculosis, and lung cancer: A preliminary study

Transcriptionally Active Lung Microbiome And Its Association With Bacterial Biomass And Host Inflammatory Status

Characterization of the lung microbiome and exploration of potential bacterial biomarkers for lung cancer

Altered Intestinal Microbiota and Fecal Metabolites in Patients with Latent and Active Pulmonary Tuberculosis

Distinct Lung Microbial Community States in Patients with Pulmonary Tuberculosis

Metagenomic Analysis of the Lung Microbiome in Pulmonary Tuberculosis-a Pilot Study

Diminishing Microbiome Richness and Distinction in the Lower Respiratory Tract of Lung Cancer Patients: A Multiple Comparative Study Design with Independent Validation.

Characterization of Microbiota in Cancerous Lung and the Contralateral Non-Cancerous Lung Within Lung Cancer Patients

Upper respiratory tract mycobiome alterations in different kinds of pulmonary disease

A Preliminary Study of Microbiota Diversity in Saliva and Bronchoalveolar Lavage Fluid from Patients with Primary Bronchogenic Carcinoma

The Microbiome of Lower Respiratory Tract and Tumor Tissue in Lung Cancer Manifested As Radiological Ground-Glass Opacity

Difference Of Lower Airway Microbiome In Bilateral Protected Specimen Brush Between Lung Cancer Patients With Unilateral Lobar Masses And Control Subjects

Alteration of the gut microbiota in patients with lung cancer accompanied by chronic obstructive pulmonary diseases

Lung microbiome and cytokine profiles in different disease states of COPD: a cohort study

The Composition Alteration of Respiratory Microbiota in Lung Cancer

Diagnostic Value of the Microbiome in the Bronchoalveolar Fluid of Patients with Lung masses and its Relationship with their Clinical Features

[A Comparative Study on the Difference of Gut Microbiota and Its Biomarkers Between Patients with Pulmonary Tuberculosis and Healthy Controls].

Lower respiratory tract microbiome and lung cancer risk prediction in patients with diffuse lung parenchymal lesions

Characteristics of the pulmonary microbiota in patients with mild and severe pulmonary infection

Alterations of lower respiratory tract microbiome and short-chain fatty acids in different segments in lung cancer: a multiomics analysis

Alternations of fecal microbes and lung tissue microbes in Lung Cancer patients is more consistent than that of sputum